The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Moleculin Biotech, Inc(NASDAQ:MBRX) 
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates for the treatment of highly resistant tumors and viruses in the United States. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or r...
Website: http://www.moleculin.com
Founded: 2015
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
Moleculin Biotech Days Payable Outstanding ttm (DPO)
Moleculin Biotech Days Receivable Outstanding ttm (DSO)
Moleculin Biotech Op Cashflow Per Share ttm
Moleculin Biotech Free Cashflow Per Share ttm
Moleculin Biotech Cash Per Share ttm
Moleculin Biotech P/S ratio ttm
Moleculin Biotech (GAAP) P/E ratio ttm
Moleculin Biotech P/B ratio ttm
No extra charts and metrics for this ticker.